Ke Lu, Li Gang, Mao Wenjian, Doig Gordon, Chen Tao, Li Chao, Qu Cheng, Wang Lanting, Gao Lin, He Wenhua, Xia Liang, Guo Feng, Lin Yongjun, Feng Quanxin, Liu Zhiyong, Li Baiqiang, Jaber Samir, Papachristou Georgios, Zhu Yin, Liu Yuxiu, Windsor John, Tong Zhihui, Li Weiqin
Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
National Institute of Healthcare Data Science, Nanjing University, Nanjing, Jiangsu, China.
Intensive Care Med. 2025 Jul 14. doi: 10.1007/s00134-025-08020-x.
Acute necrotic collection (ANC) is an early, local complication of necrotizing pancreatitis, and guidelines recommend a deliberate delay in treating ANC. In patients with early persistent organ failure, such delay may be harmful. This study aimed to assess whether early intervention for ANC confers clinical benefits in this patient population.
This is a multicenter, open-label, randomized controlled trial. At 7 days after disease onset, patients with ANC and persistent organ failure were screened for: (1) organ failure lasting longer than 7 days; (2) organ failure worsening in severity; or (3) new-onset organ failure. If one or more criteria were met, they were randomized to receive either early percutaneous catheter drainage or standard care. The primary outcome was a composite of major complications and/or death during the index admission.
Overall, 120 patients were randomized to early intervention (N = 63) or standard care (N = 57). There was no difference in the primary composite outcome (33.3% [21/63] versus 36.8% [21/57]; risk difference [RD] - 3.5%; 95% CI, - 20.6 to 13.6%) or the individual components, including mortality. The study groups did not differ in terms of organ failure free days to 21 days after randomization (4 days [interquartile range 0-14] versus 1 day [interquartile range 0-15]). The requirement for minimally invasive debridement and open surgery was comparable between groups.
Early catheter drainage for ANCs in patients with necrotizing pancreatitis and early persistent organ failure, compared with standard delayed care, did not improve clinical outcomes. Future larger trials are needed to confirm our findings.
急性坏死性液体积聚(ANC)是坏死性胰腺炎的一种早期局部并发症,指南建议对ANC进行延迟治疗。对于早期持续性器官衰竭的患者,这种延迟可能有害。本研究旨在评估对该患者群体的ANC进行早期干预是否具有临床益处。
这是一项多中心、开放标签、随机对照试验。在疾病发作7天后,对患有ANC和持续性器官衰竭的患者进行筛查:(1)器官衰竭持续超过7天;(2)器官衰竭严重程度恶化;或(3)新发器官衰竭。如果满足一项或多项标准,则将他们随机分组,分别接受早期经皮导管引流或标准治疗。主要结局是本次住院期间的主要并发症和/或死亡的复合结局。
总体而言,120例患者被随机分配至早期干预组(N = 63)或标准治疗组(N = 57)。主要复合结局无差异(33.3% [21/63] 对36.8% [21/57];风险差异 [RD] -3.5%;95% CI,-20.6至13.6%),各单项指标包括死亡率也无差异。随机分组后至21天无器官衰竭天数在研究组间无差异(4天 [四分位间距0 - 14] 对1天 [四分位间距0 - 15])。两组间微创清创术和开放手术的需求相当。
与标准延迟治疗相比,坏死性胰腺炎且早期持续性器官衰竭患者的ANC早期导管引流并未改善临床结局。需要未来更大规模的试验来证实我们的发现。